Ascend Wellness (AAWH) Q1 2025 earnings summary

Executive summary

• Q1 2025 net revenue was $128 million, with adjusted EBITDA of $27 million and a 21.1% margin, maintaining profitability despite price compression and market contraction.

• Market share grew 4% sequentially, even as core markets contracted by 3.4%.

• Strategic focus on retail densification, margin improvement, and customer engagement, with plans to open ten new stores in 2025 and a mid-term target of a 50% increase in store base.

• Cost-saving initiatives exceeded $30 million annualized, supporting margin resilience and positive operating cash flow for the ninth consecutive quarter.

• Next-generation e-commerce rollout and revamped loyalty program drove higher customer engagement and order values.

Financial highlights

• Net revenue declined 5.9% sequentially and 10% year-over-year, mainly due to retail softness, price compression, and lower volumes.

• Adjusted EBITDA was $27 million, down 10.7% sequentially and 10.6% year-over-year, with margin decreasing by 1.1%.

• Ended Q1 with $100 million in cash, up $11.8 million from year-end, and net debt of $233 million.

• Free cash flow was $1.2 million after capital expenditures.

• Net loss increased to $19.3 million from $16.8 million in Q4 2024, primarily due to lower gross margins.

Outlook and guidance

• Management expects densification strategy and retail initiatives to deliver measurable benefits in the second half of 2025.

• Plans to open ten new stores in 2025, including three in Ohio and one in Pennsylvania, and expand partner locations in Illinois and New Jersey.

• CapEx for 2025 projected at $30–$35 million, about half allocated to new store openings.

• Anticipates further margin improvement as automation and cost initiatives take full effect and as store mix becomes more vertical.

• Further upside expected as medical markets transition to adult-use, especially in Ohio and Pennsylvania.